How would you manage a patient with MSS, KRAS mutated locally advanced rectal adenocarcinoma with a mixed response to neoadjuvant FOLFOX?  

This involves the primary site responding but progression with new bone marrow involvement with resulting cytopenias.



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Ironwood Cancer and Research Centers
Thank you for the response. Yes, a bone marrow bio...
Medical Oncologist at Dignity Health Cancer Institute
In this patient with metastatic disease and change...
Medical Oncologist at Ironwood Cancer and Research Centers
Thank you, Dr. @Mital S. Patel for your input. The...
Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
Actually, you may expect to see improved cytopenia...
Sign in or Register to read more